drugset / Trial / NCT03998423
Oral Fecal Microbiota Transplant Feasibility Study in Alzheimer's Disease
Phase 1
Terminated
5 enrolled
University of Wisconsin, Madison
Wisconsin Partnership Program · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The goal of this study is to assess the safety and feasibility of an oral fecal microbiota transplant (FMT) intervention for Alzheimer's disease (AD).
Timeline
- Start
- 2019-11-14
- Primary completion
- 2020-07-14
- Completion
- 2020-07-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fecal Microbiota Transplant | Other / unclassified | 22.5 g | Oral |